Q9UQF2 (JIP1_HUMAN) Homo sapiens (Human)
C-Jun-amino-terminal kinase-interacting protein 1 UniProtKBInterProSTRINGInteractive Modelling
711 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
26 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
Crystal structure of a cysteine-deficient mutant M7 in MAP kinase JNK1 |
Heteromer P45983; | 1×SO4; 1×TRS; | ||||
Assess | ||||||
Crystal structure of the TPR domain of KLC1 in complex with the C-terminal peptide of JIP1 |
Heteromer O88447; | 1×GOL; | ||||
Assess | ||||||
Crystal Structure of JNK3 in Complex with JIP1 Peptide |
Heteromer P53779; | |||||
Assess | ||||||
Design and Synthesis of Disubstituted Thiophene and Thiazole Based Inhibitors of JNK for the Treatm… |
Heteromer P53779; | 1×SYY; | ||||
Assess | ||||||
Design and Synthesis of a Novel, Orally Efficacious Tri-substituted Thiophene Based JNK Inhibitor |
Heteromer P53779; | 1×932; | ||||
Assess | ||||||
Crystal structure of a cysteine-deficient mutant M3 in MAP kinase JNK1 |
Heteromer P45983; | 5×SO4; 1×GOL; | ||||
Assess | ||||||
Crystal structure of a cysteine-deficient mutant M2 in MAP kinase JNK1 |
Heteromer P45983; | 5×SO4; | ||||
Assess | ||||||
Crystal structure of a cysteine-deficient mutant M1 in MAP kinase JNK1 |
Heteromer P45983; | |||||
Assess | ||||||
Crystal structure of a cysteine-deficient mutant M5 in MAP kinase JNK1 |
Heteromer P45983; | 3×SO4; | ||||
Assess | ||||||
Discovery of Potent, Highly Selective, and Orally Bioavailable Pyridine Carboxamide C-jun NH2-termi… |
Heteromer P45983; | 2×SO4; 1×893; 1×GOL; | ||||
Assess | ||||||
Crystal structure of a cysteine-deficient mutant M2 in MAP kinase JNK1 |
Heteromer P45983; | 4×SO4; | ||||
Assess | ||||||
Crystal structure of a cysteine-deficient mutant M1 in MAP kinase JNK1 |
Heteromer P45983; | 1×SO4; | ||||
Assess | ||||||
Pyrazoloquinolones as Novel, Selective JNK1 inhibitors |
Heteromer P45983; | 2×SO4; 1×73Q; | ||||
Assess | ||||||
Selective Aminopyridine-Based C-Jun N-terminal Kinase inhibitors with cellular activity |
Heteromer P45983; | 2×SO4; 1×877; | ||||
Assess | ||||||
Crystal structure of JNK1 in complex with JIP1 peptide and 4-{4-[4-(3-Methanesulfonyl-propoxy)-inda… |
Heteromer P45983; | 1×1BK; | ||||
Assess | ||||||
Crystal structure of JNK1beta-JIP in complex with an azaquinolone inhbitor |
Heteromer P45983; | 1×0NR; | ||||
Assess | ||||||
Crystal structure of JNK1 in complex with JIP1 peptide and 4-{4-[4-(4-Methanesulfonyl-piperidin-1-y… |
Heteromer P45983; | 1×1J2; | ||||
Assess | ||||||
Crystal structure of JNK1 in complex with JIP1 peptide and 4-(4-Indazol-1-yl-pyrimidin-2-ylamino)-c… |
Heteromer P45983; | 1×1BJ; | ||||
Assess | ||||||
Crystal structure of JNK1 in complex with JIP1 peptide and 7-Fluoro-3-[4-(2-hydroxy-ethanesulfonyl)… |
Heteromer P45983; | 1×G1W; | ||||
Assess | ||||||
Crystal structure of DARPin-DARPin rigid fusion, variant DD_232_11_D12 in complex JNK1a1 and JIP1 p… |
Heteromer P45983; | 7×SO4; 1×ADN; | ||||
Assess | ||||||
SH3 domain of JNK-interacting Protein 1 (JIP1) | homo-2-mer | |||||
Assess | ||||||
Mutant Y526A of SH3 domain of JNK-interacting Protein 1 (JIP1) | homo-2-mer | 1×PO4; 3×1PE; 1×EDO; 1×PG4; | ||||
Assess | ||||||
Mutant V517L of the SH3 domain of JNK-interacting protein 1 (JIP1) | homo-2-mer | 1×PO4; 1×PG4; | ||||
Assess | ||||||
Mutant A541L of SH3 domain of JNK-interacting Protein 1 (JIP1) | homo-2-mer | 2×PG4; 1×SO4; | ||||
Assess | ||||||
Mutant V517A - SH3 domain of JNK-interacting Protein 1 (JIP1) | homo-2-mer | 2×SO4; 2×P6G; 1×PO4; | ||||
Assess | ||||||
Mutant H493A of SH3 domain of JNK-interacting Protein 1 (JIP1) | homo-2-mer | 1×PG4; 1×GLC; | ||||
Assess |
1 SWISS-MODEL model
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
6itu.1.A | monomer | 0.62 | 31.82 | |||
Assess |